- Home
- SCLX vs MLSS Comparison
SCLX vs MLSS Comparison
Compare SCLX & MLSS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SCLX
- MLSS
- Stock Information
- Founded
- SCLX 2011
- MLSS 1989
- Country
- SCLX United States
- MLSS United States
- Employees
- SCLX N/A
- MLSS N/A
- Industry
- SCLX Biotechnology: Pharmaceutical Preparations
- MLSS Industrial Specialties
- Sector
- SCLX Health Care
- MLSS Health Care
- Exchange
- SCLX Nasdaq
- MLSS Nasdaq
- Market Cap
- SCLX 35.7M
- MLSS 42.4M
- IPO Year
- SCLX N/A
- MLSS 1995
- Fundamental
- Price
- SCLX $26.28
- MLSS $0.59
- Analyst Decision
- SCLX Strong Buy
- MLSS Buy
- Analyst Count
- SCLX 3
- MLSS 1
- Target Price
- SCLX $367.50
- MLSS $1.25
- AVG Volume (30 Days)
- SCLX 230.4K
- MLSS 71.0K
- Earning Date
- SCLX 08-13-2025
- MLSS 11-13-2025
- Dividend Yield
- SCLX N/A
- MLSS N/A
- EPS Growth
- SCLX N/A
- MLSS N/A
- EPS
- SCLX N/A
- MLSS N/A
- Revenue
- SCLX $44,236,000.00
- MLSS $9,083,205.00
- Revenue This Year
- SCLX $89.26
- MLSS $17.24
- Revenue Next Year
- SCLX $203.95
- MLSS $14.58
- P/E Ratio
- SCLX N/A
- MLSS N/A
- Revenue Growth
- SCLX N/A
- MLSS 7.84
- 52 Week Low
- SCLX $3.60
- MLSS $0.38
- 52 Week High
- SCLX $41.30
- MLSS $1.39
- Technical
- Relative Strength Index (RSI)
- SCLX 76.74
- MLSS 46.61
- Support Level
- SCLX $23.90
- MLSS $0.55
- Resistance Level
- SCLX $19.73
- MLSS $0.65
- Average True Range (ATR)
- SCLX 1.85
- MLSS 0.04
- MACD
- SCLX 0.50
- MLSS -0.00
- Stochastic Oscillator
- SCLX 91.79
- MLSS 40.00
About SCLX Scilex Holding Company
Scilex Holding Co is focused on acquiring, developing, and commercializing non-opioid pain management products for the treatment of acute and chronic pain. The Company's commercial product, ZTlido (lidocaine topical system), is a prescription lidocaine topical product for relieving pain associated with postherpetic neuralgia, which is a form of post-shingles nerve pain. It is focused on commercializing Gloperba (colchicine USP) an oral solution, a prophylactic treatment for painful gout flares in adults. The Company's three product candidates are SP-102 or SEMDEXA viscous gel formulation of a used corticosteroid for epidural injections, SP-103 a Phase 2, triple-strength formulation of ZTlido, and SP-104, 4.5 mg Delayed Burst Release Low Dose Naltrexone Hydrochloride (DBR-LDN) Capsule.
About MLSS Milestone Scientific Inc.
Milestone Scientific Inc is a biomedical technology company. The company is engaged in pioneering proprietary, technological systems and solutions for the medical and dental markets. The company develops, manufactures, markets, and sells the computer-controlled system for the improved and painless delivery of local anesthetics. The system is marketed in dentistry under the trademark CompuDent and in medicine under the trademark CompuMed. The Company conducts its business through two reportable segments: Dental and Medical.